SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4,568.89 |
| Enterprise Value ($M) | 4,210.56 |
| Book Value ($M) | 778.64 |
| Book Value / Share | 27.31 |
| Price / Book | 5.87 |
| NCAV ($M) | 548.20 |
| NCAV / Share | 19.23 |
| Price / NCAV | 8.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | 0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.55 |
| Current Ratio | 17.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 587.91 |
| Assets | 818.36 |
| Liabilities | 39.71 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 50.70 |
| Operating Income | -97.23 |
| Net Income | 10.93 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -88.80 |
| Cash from Investing | 82.64 |
| Cash from Financing | 202.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avoro Capital Advisors LLC | 9.10 | 81.95 | |
| 13G/A | Redmile Group, LLC | 6.10 | -8.62 | |
| 13G | Vanguard Group Inc | 8.64 | ||
| 13G/A | Fmr Llc | 11.87 | 40.39 | |
| 13G/A | BlackRock Inc. | 6.40 | 6.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 82,733 | 368,070 | 22.48 | |
| 30,677 | 109,817 | 27.93 | |
| 78,671 | 173,164 | 45.43 | |
| 46,845 | 102,558 | 45.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KPTI – Karyopharm Therapeutics Inc. |
| KRON – Kronos Bio, Inc. | KURA – Kura Oncology, Inc. |
| KYTX – Kyverna Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io